Cellebrite DI Capital Reinvestment Ratio
Cellebrite DI capital reinvestment ratio. Cellebrite DI (CLBT) has a Capital Reinvestment Ratio of 0.05x as of December 2025, meaning it reinvests 0% of its operating cash flow ($82.23 Million) in capital expenditures ($3.96 Million). Check total reinvestment intensity of Cellebrite DI to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Cellebrite DI (2019–2025)
Capital reinvestment ratio of Cellebrite DI from 2019 to 2025. This chart tracks Cellebrite DI's Capital Reinvestment Ratio across 7 annual periods. Also explore Cellebrite DI equity growth rate to track the company's year-over-year net asset growth rate.
Cellebrite DI Capital Reinvestment Ratio by Year (2019–2025)
Cellebrite DI capital reinvestment ratio by year from 2019 to 2025. For the full cash flow conversion analysis, see CLBT cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.08x | $168.96 Million | $13.22 Million | ▼ -2.5% |
| 2024 | 0.08x | $132.17 Million | $10.61 Million | ▲ +3.5% |
| 2023 | 0.08x | $102.06 Million | $7.92 Million | ▼ -82.4% |
| 2022 | 0.44x | $20.58 Million | $9.09 Million | ▲ +96.2% |
| 2021 | 0.22x | $36.05 Million | $8.11 Million | ▲ +142.1% |
| 2020 | 0.09x | $66.51 Million | $6.18 Million | ▼ -75.9% |
| 2019 | 0.38x | $16.13 Million | $6.21 Million | — |